National Medical Care Company (4005.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for National Medical Care Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,600↑23.7% | 1,294↑19.6% | 1,082↑17.8% | 918↑8.6% | 845 | |
| Cost of Revenue | 1,011↑20.4% | 840↑17.9% | 712↑13.4% | 628↑4.9% | 599 | |
| Gross Profit | 589↑29.7% | 454↑22.8% | 370↑27.6% | 290↑17.5% | 246 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 43↓5.8% | 45↑9.5% | 41↑89.4% | 22↑15.0% | 19 | |
| Selling & Marketing Expenses | 20↑80.7% | 11↑32.7% | 9↑91.0% | 4↓62.7% | 12 | |
| SG&A Expenses | 63↑11.5% | 57↑13.5% | 50↑89.7% | 26↓15.0% | 31 | |
| Other Expenses | 171↑69.9% | 101 | 0.00↓100.0% | 66↑11.3% | 59 | |
| Operating Expenses | 234↑48.9% | 157↑27.9% | 123↑33.2% | 92↑2.2% | 90 | |
| Total Costs & Expenses | 1,245↑24.9% | 997↑19.4% | 835↑15.9% | 721↑4.6% | 689 | |
| Operating Results | ||||||
| Operating Income | 355↑19.6% | 297↑20.3% | 247↑25.0% | 197↑27.1% | 155 | |
| Depreciation & Amortization | 111↑37.5% | 80↑46.5% | 55↑20.2% | 46↓8.9% | 50 | |
| EBITDA | 484↑22.0% | 397↑22.9% | 323↑32.3% | 244↑13.8% | 215 | |
| EBIT | 373↑18.0% | 316↑18.0% | 268↑35.1% | 199↑21.5% | 163 | |
| Interest & Other Income | ||||||
| Net Interest Income | -8↓151.0% | -3↓118.2% | 18↑1345.1% | 1↑490.5% | 0.21 | |
| Interest Income | 19↓3.5% | 19↓8.8% | 21↑1627.7% | 1↑490.5% | 0.21 | |
| Interest Expense | 27↑18.6% | 23↑550.4% | 3 | 0.00 | 0.00 | |
| Non-Operating Income | -19↑3.5% | -19↑8.8% | -21↓1627.7% | -1↓218.9% | 1 | |
| Other Income / Expenses | 0.00↑100.0% | -3↓118.2% | 18↑1345.1% | 1 | 0.00 | |
| Income Before Tax | 355↑20.9% | 294↑11.0% | 265↑33.3% | 199↑20.7% | 164 | |
| Income Tax Expense | 37↑915.7% | -5↓119.2% | 24↓16.7% | 28↑1.4% | 28 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 318↑6.7% | 298↑23.8% | 241↑41.7% | 170↑24.7% | 136 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 318↑6.7% | 298↑23.8% | 241↑41.7% | 170↑24.7% | 136 | |
| Bottom-Line Net Income | 318↑6.7% | 298↑23.8% | 241↑41.7% | 170↑24.7% | 136 | |
| EPS (Basic) | 7.13↑7.2% | 6.65↑23.8% | 5.37↑41.7% | 3.79↑24.7% | 3.04 | |
| EPS (Diluted) | 7.13↑7.2% | 6.65↑23.8% | 5.37↑41.7% | 3.79↑24.7% | 3.04 | |
| Weighted Average Shares | 45↓0.4% | 45↓0.2% | 45↑0.0% | 45↑0.0% | 45 | |
| Weighted Average Diluted Shares | 45↓0.4% | 45↓0.2% | 45↑0.0% | 45↑0.0% | 45 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.